Mountain Crest Acquisition Corp. II (MCADU)

Etorro trading 970x250

About Mountain Crest Acquisition Corp. II

Mountain Crest Acquisition Corp. II, a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Address: 311 West 43rd Street, New York, NY, United States, 10036

Mountain Crest Acquisition Corp. II News and around…

Latest news about Mountain Crest Acquisition Corp. II (MCADU) common stock and company :

Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.
27 Oct, 2021 Yahoo! Finance

Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to approve its proposed business combination (the “business combination”) with Better Therapeutics Inc. (“Better Therapeutics”), a company engaged in

Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021
13 Oct, 2021 Yahoo! Finance

NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCAD’s registration statement on Form S-4 (File No. 333-255493) relating to the previously an

Moore Kuehn Encourages EBMT, ESBK, BCML, and MCAD Investors to Contact Law Firm
07 Oct, 2021 Yahoo! Finance

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Eagle Bancorp Montana, Inc. (NASDAQ GM: EBMT) Eagle Bancorp has agreed to merge with First Commu

Better Therapeutics to Participate in Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021
10 Sep, 2021 Yahoo! Finance

SAN FRANCISCO, September 10, 2021--Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has been invited to present at the Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference, which is being held virtually on September 14-15, 2021.

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022
09 Sep, 2021 Yahoo! Finance

SAN FRANCISCO, September 09, 2021--Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today provided an update on recent progress since announcing its intention to merge with Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) ("Mountain Crest II"). The merger and concurrent PIPE and debt financings are expected to close in October.

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network
24 Aug, 2021 Yahoo! Finance

SAN FRANCISCO, August 24, 2021--Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, in partnership with Catalyst Health Network ("Catalyst"), today announced the commencement of a real-world evidence study to evaluate the long-term effectiveness and healthcare utilization changes associated with the use of BT-001 for the treatment of type 2 diabetes. Catalyst

Lifshitz Law Firm, P.C. Announces Investigation of BMTC, WSFS, CAHC, CBAN, SCSG, INDB, EBSB, INSW, DSSI, MCAD, VER and O
04 May, 2021 Yahoo! Finance

Bryn Mawr Bank Corporation (NASDAQ: BMTC) - WSFS Financial Corp. (NASDAQGS: WSFS)

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contact the Firm
29 Apr, 2021 Yahoo! Finance

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Mountain Crest Acquisition Corp. II Merger
27 Apr, 2021 Yahoo! Finance

WILMINGTON, Del., April 26, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Mountain Crest Acquisition Corp. II (“Mountain Crest II”) (NASDAQ: MCAD) regarding possible breaches of fiduciary duties and other violations of law related to Mountain Crest II’s agreement to merge with Better Therapeutics, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases- mountain-crest-acquisition-corp-ii You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising. Prior results do not guarantee a similar outcome. CONTACT: Rigrodsky Law, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Mountain Crest Acquisition Corp. II - MCAD
24 Apr, 2021 Yahoo! Finance

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Mountain Crest Acquisition Corp. II ("MCAD" or the "Company") (MCAD) relating to its proposed merger with Better Therapeutics. Under the terms of the agreement, MCAD will acquire Better through a reverse merger, with Better emerging as a publicly traded company.

Better Therapeutics Launches Real World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes
14 Apr, 2021 Yahoo! Finance

Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the commencement of a real-world evidence study with Steward Health Care to evaluate the long-term effectiveness and cost of care impact associated with the use of BT-001 for the treatment of type 2 diabetes. BT-001 is an investigational, prescription digital therapeutic that delivers a novel form of cognitive behavioral therapy to patients with uncontrolled type 2 diabetes.

Moore Kuehn Encourages MUDS, ROT, CAHC, and MCAD Investors to Contact Law Firm
12 Apr, 2021 Yahoo! Finance

NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Mudrick Capital Acquisition Corp II (NASDAQ: MUDS) Mudrick Capital Acquisition Corp II has agreed to merge with Topps Co. Under the proposed transaction, Mudrick shareholders will own only 28% of the combined company. Rotor Acquisition Corp. (NYSE: ROT) Rotor Acquisition Corp. has agreed to merge with Sarcos Robotics. Under the proposed transaction, Rotor Acquisition shareholders will own just 15.7% of the combined company. CA Healthcare Acquisition Corp. (NASDAQ: CAHC) CA Healthcare Acquisition Corp. has agreed to merge with LumiraDx. Under the proposed transaction, CA Healthcare shareholders will own only 2.2% of the combined company. Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) Mountain Crest Acquisition Corp. II has agreed to merge with Better Therapeutics. Under the proposed transaction, Mountain Crest shareholders will retain only 20.4% of the combined company. Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Moore Kuehn is a 5-star Google rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts:Moore Kuehn, PLLCJustin Kuehn, Esq.30 Wall Street, 8th FloorNew York, New York 10005jkuehn@moorekuehn.com(212) 709-8245

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Mountain Crest Acquisition Corp. II (Nasdaq - MCAD)
07 Apr, 2021 Yahoo! Finance

BALA CYNWYD, PA / ACCESSWIRE / April 7, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Mountain Crest Acquisition Corp. II ("Mountain Crest" or the "Company") (Nasdaq:MCAD) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Mountain Crest, a special purpose acquisition company, will combine with Better Therapeutics, Inc.

Better Therapeutics To Go Public Via Mountain Crest SPAC Deal
07 Apr, 2021 FinancialContent

Better Therapeutics Inc, a company developing prescription-only smartphone-based treatments for Type 2 diabetes and high blood ...

Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquisition Corp. II
07 Apr, 2021 Yahoo! Finance

Better Therapeutics, Inc. a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, will go public, raising up to $113 million to advance its robust pipeline of products to treat cardiometabolic diseases, conditions which cost the U.S. healthcare system almost $500 billion each year. Better Therapeutics has entered into a definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD; "Mountain Crest II"), a publicly traded special purpose acquisition corporation or SPAC. The transaction values Better Therapeutics at a pro forma fully diluted enterprise value of approximately $187 million with existing Better Therapeutics shareholders rolling over 100% of their equity into equity of the combined company. Upon completion of the transaction, which is anticipated in the summer 2021, the combined company will operate as Better Therapeutics and securities are expected to be listed on Nasdaq under the symbol "BTTX."

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17, 2021
15 Mar, 2021 FinancialContent
Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
15 Jan, 2021 FinancialContent
Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering
13 Jan, 2021 FinancialContent

Mountain Crest Acquisition Corp. II (MCADU) is a NASDAQ Common Stock listed in , ,

970x250